Literature DB >> 24748494

CD8 T cells use IFN-γ to protect against the lethal effects of a respiratory poxvirus infection.

John Goulding1, Georges Abboud1, Vikas Tahiliani1, Pritesh Desai1, Tarun E Hutchinson1, Shahram Salek-Ardakani2.   

Abstract

CD8 T cells are a key component of immunity to many viral infections. They achieve this through using an array of effector mechanisms, but precisely which component/s are required for protection against a respiratory orthopox virus infection remains unclear. Using a model of respiratory vaccinia virus infection in mice, we could specifically determine the relative contribution of perforin, TRAIL, and IFN-γ-mediated pathways in protection against virus induced morbidity and mortality. Unexpectedly, we observed that protection against death was mediated by IFN-γ without any involvement of the perforin or TRAIL-dependent pathways. IFN-γ mRNA and protein levels in the lung peaked between days 3 and 6 postinfection. This enhanced response coincided with the emergence of virus-specific CD8 T cells in the lung and the cessation of weight loss. Transfer experiments indicated that CD8 T cell-autonomous expression of IFN-γ restricts virus-induced lung pathology and dissemination to visceral tissues and is necessary for clearance of virus. Most significantly, we show that CD8 T cell-derived IFN-γ is sufficient to protect mice in the absence of CD4 and B-lymphocytes. Thus, our findings reveal a previously unappreciated mechanism by which effector CD8 T cells afford protection against a highly virulent respiratory orthopox virus infection.
Copyright © 2014 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24748494      PMCID: PMC4036466          DOI: 10.4049/jimmunol.1400256

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  72 in total

1.  Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever.

Authors:  S Kettle; A Alcamí; A Khanna; R Ehret; C Jassoy; G L Smith
Journal:  J Gen Virol       Date:  1997-03       Impact factor: 3.891

2.  Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.

Authors:  H H Nguyen; F W van Ginkel; H L Vu; M J Novak; J R McGhee; J Mestecky
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase.

Authors:  K Carroll; O Elroy-Stein; B Moss; R Jagus
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

4.  Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model.

Authors:  T A Brandt; B L Jacobs
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-gamma interferon-treated mice.

Authors:  T P Leist; M Eppler; R M Zinkernagel
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

6.  A study of the vaccinia virus interferon-gamma receptor and its contribution to virus virulence.

Authors:  Julian A Symons; David C Tscharke; Nicola Price; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2002-08       Impact factor: 3.891

7.  Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins.

Authors:  K Mossman; C Upton; R M Buller; G McFadden
Journal:  Virology       Date:  1995-04-20       Impact factor: 3.616

8.  Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication.

Authors:  N Harris; R M Buller; G Karupiah
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

9.  Vaccinia virus zoonotic infection, São Paulo State, Brazil.

Authors:  Jane Megid; Iara A Borges; Jonatas S Abrahão; Giliane S Trindade; Camila M Appolinário; Márcio G Ribeiro; Susan D Allendorf; João Marcelo A P Antunes; André T Silva-Fernandes; Erna G Kroon
Journal:  Emerg Infect Dis       Date:  2012-01       Impact factor: 6.883

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  21 in total

1.  Inflammatory monocytes contribute to the persistence of CXCR3hi CX3CR1lo circulating and lung-resident memory CD8+ T cells following respiratory virus infection.

Authors:  Pritesh Desai; Vikas Tahiliani; Jessica Stanfield; Georges Abboud; Shahram Salek-Ardakani
Journal:  Immunol Cell Biol       Date:  2018-01-30       Impact factor: 5.126

2.  The TNF Superfamily Molecule LIGHT Promotes the Generation of Circulating and Lung-Resident Memory CD8 T Cells following an Acute Respiratory Virus Infection.

Authors:  Pritesh Desai; Vikas Tahiliani; Tarun E Hutchinson; Farhad Dastmalchi; Jessica Stanfield; Georges Abboud; Paul G Thomas; Carl F Ware; Jianxun Song; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2018-03-07       Impact factor: 5.422

3.  Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.

Authors:  Georges Abboud; Vikas Tahiliani; Pritesh Desai; Kyle Varkoly; John Driver; Tarun E Hutchinson; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

4.  Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity.

Authors:  Ariana G Bravo Cruz; Aiguo Han; Edward J Roy; Arielle B Guzmán; Rita J Miller; Elizabeth A Driskell; William D O'Brien; Joanna L Shisler
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

5.  Batf3-Dependent Dendritic Cells Promote Optimal CD8 T Cell Responses against Respiratory Poxvirus Infection.

Authors:  Pritesh Desai; Vikas Tahiliani; Georges Abboud; Jessica Stanfield; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2018-07-31       Impact factor: 5.103

6.  Both CD8+ and CD4+ T Cells Contribute to Corneal Clouding and Viral Clearance following Vaccinia Virus Infection in C57BL/6 Mice.

Authors:  I V Larsen; H Clausius; A W Kolb; C R Brandt
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

7.  Lack of B Lymphocytes Enhances CD8 T Cell-Mediated Resistance against Respiratory Viral Infection but Compromises Memory Cell Formation.

Authors:  Pritesh Desai; Jessica Stanfield; Vikas Tahiliani; Georges Abboud; Shahram Salek-Ardakani
Journal:  J Virol       Date:  2020-01-17       Impact factor: 5.103

8.  HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.

Authors:  Pritesh Desai; Georges Abboud; Jessica Stanfield; Paul G Thomas; Jianxun Song; Carl F Ware; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

Review 9.  Distinct roles of TNF-related apoptosis-inducing ligand (TRAIL) in viral and bacterial infections: from pathogenesis to pathogen clearance.

Authors:  Valeriya Gyurkovska; Nina Ivanovska
Journal:  Inflamm Res       Date:  2016-03-04       Impact factor: 4.575

10.  Airway CD8(+) T Cells Are Associated with Lung Injury during Infant Viral Respiratory Tract Infection.

Authors:  Thomas J Connors; Thyyar M Ravindranath; Kara L Bickham; Claire L Gordon; Feifan Zhang; Bruce Levin; John S Baird; Donna L Farber
Journal:  Am J Respir Cell Mol Biol       Date:  2016-06       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.